No Cover Image

Journal article 1451 views 166 downloads

Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?

Alwena Morgan Orcid Logo, Daniel Rees Orcid Logo, Zane B. Andrews, Jeffrey Davies Orcid Logo

Neuropharmacology, Volume: 136, Pages: 317 - 326

Swansea University Authors: Alwena Morgan Orcid Logo, Daniel Rees Orcid Logo, Jeffrey Davies Orcid Logo

  • 38126.pdf

    PDF | Accepted Manuscript

    Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).

    Download (1.15MB)

Check full text

DOI (Published version): 10.1016/j.neuropharm.2017.12.027

Published in: Neuropharmacology
ISSN: 00283908
Published: 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa38126
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2018-01-16T20:11:47Z
last_indexed 2018-07-25T13:28:31Z
id cronfa38126
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2018-07-25T12:07:59.3348998</datestamp><bib-version>v2</bib-version><id>38126</id><entry>2018-01-16</entry><title>Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?</title><swanseaauthors><author><sid>9ea39c3d0935c897cb9fcd3ba550af71</sid><ORCID>0000-0002-3441-5357</ORCID><firstname>Alwena</firstname><surname>Morgan</surname><name>Alwena Morgan</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>daa6762111f9ebf62b9c2ec655512783</sid><ORCID>0000-0003-0372-6096</ORCID><firstname>Daniel</firstname><surname>Rees</surname><name>Daniel Rees</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>2cb3d1d96a7870a84d2f758e865172e6</sid><ORCID>0000-0002-4234-0033</ORCID><firstname>Jeffrey</firstname><surname>Davies</surname><name>Jeffrey Davies</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-01-16</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Neuropharmacology</journal><volume>136</volume><paginationStart>317</paginationStart><paginationEnd>326</paginationEnd><publisher/><issnPrint>00283908</issnPrint><keywords/><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-07-01</publishedDate><doi>10.1016/j.neuropharm.2017.12.027</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2018-07-25T12:07:59.3348998</lastEdited><Created>2018-01-16T13:26:11.9728890</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Alwena</firstname><surname>Morgan</surname><orcid>0000-0002-3441-5357</orcid><order>1</order></author><author><firstname>Daniel</firstname><surname>Rees</surname><orcid>0000-0003-0372-6096</orcid><order>2</order></author><author><firstname>Zane B.</firstname><surname>Andrews</surname><order>3</order></author><author><firstname>Jeffrey</firstname><surname>Davies</surname><orcid>0000-0002-4234-0033</orcid><order>4</order></author></authors><documents><document><filename>0038126-15022018122840.pdf</filename><originalFilename>38126.pdf</originalFilename><uploaded>2018-02-15T12:28:40.4070000</uploaded><type>Output</type><contentLength>1181763</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-12-23T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2018-07-25T12:07:59.3348998 v2 38126 2018-01-16 Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease? 9ea39c3d0935c897cb9fcd3ba550af71 0000-0002-3441-5357 Alwena Morgan Alwena Morgan true false daa6762111f9ebf62b9c2ec655512783 0000-0003-0372-6096 Daniel Rees Daniel Rees true false 2cb3d1d96a7870a84d2f758e865172e6 0000-0002-4234-0033 Jeffrey Davies Jeffrey Davies true false 2018-01-16 BMS Journal Article Neuropharmacology 136 317 326 00283908 1 7 2018 2018-07-01 10.1016/j.neuropharm.2017.12.027 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2018-07-25T12:07:59.3348998 2018-01-16T13:26:11.9728890 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Alwena Morgan 0000-0002-3441-5357 1 Daniel Rees 0000-0003-0372-6096 2 Zane B. Andrews 3 Jeffrey Davies 0000-0002-4234-0033 4 0038126-15022018122840.pdf 38126.pdf 2018-02-15T12:28:40.4070000 Output 1181763 application/pdf Accepted Manuscript true 2018-12-23T00:00:00.0000000 Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND). true eng
title Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
spellingShingle Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
Alwena Morgan
Daniel Rees
Jeffrey Davies
title_short Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_full Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_fullStr Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_full_unstemmed Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_sort Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
author_id_str_mv 9ea39c3d0935c897cb9fcd3ba550af71
daa6762111f9ebf62b9c2ec655512783
2cb3d1d96a7870a84d2f758e865172e6
author_id_fullname_str_mv 9ea39c3d0935c897cb9fcd3ba550af71_***_Alwena Morgan
daa6762111f9ebf62b9c2ec655512783_***_Daniel Rees
2cb3d1d96a7870a84d2f758e865172e6_***_Jeffrey Davies
author Alwena Morgan
Daniel Rees
Jeffrey Davies
author2 Alwena Morgan
Daniel Rees
Zane B. Andrews
Jeffrey Davies
format Journal article
container_title Neuropharmacology
container_volume 136
container_start_page 317
publishDate 2018
institution Swansea University
issn 00283908
doi_str_mv 10.1016/j.neuropharm.2017.12.027
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2018-07-01T03:48:10Z
_version_ 1763752322871066624
score 11.037056

Similar Items